Study Arm News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Study Arm. Real-time updates on events, politics, business and more.

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

May 29, 2024

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response and two stable disease observations have occurred as of May 15,...

United Kingdom United States Prehevbrio Prehevbri Brii Biosciences Davide Anderson Jeff Baxter

Source: marketscreener.com

VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

April 3, 2024

Data highlighted in oral presentation at World Vaccine Congress 2024 on April 3, 2024 Early data from patients eligible for evaluation at week 12 show two observations of stable disease,...

United States United Kingdom Brii Biosciences Davide Anderson Prehevbrio Prehevbri Company Quarterly Reports On Form

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Study Arm News Today

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

Explore More Categories